Lower Thoracic Epidural vs Erector Spinae Block for PNL
Lower Thoracic Epidural Versus Erector Spinae Block for Postoperative Analgesia for Percutaneous Nephrolithotomy
1 other identifier
interventional
42
0 countries
N/A
Brief Summary
compare the efficacy of Lower Thoracic Epidural with Erector spinae plane block (ESPB) for post-operative analgesia after Percutaneous Nephrolithotomy with a hypothesis that both Lower Thoracic Epidural and Erector spinae plane block are effective in providing post-operative analgesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2023
CompletedFirst Posted
Study publicly available on registry
February 13, 2023
CompletedStudy Start
First participant enrolled
January 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 11, 2024
January 1, 2024
11 months
January 25, 2023
January 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total opioid consumption
Total opioid used
48 hours postoperatively
Secondary Outcomes (9)
First analgesic request
48 hours postoperatively
Pain scores
48 hours postoperatively
Analgesic drug consumption other than Nalbuphine
48 hours postoperatively
Ambulation Time
48 hours postoperatively
Patient satisfaction with anathesia
48 hours postoperativelyi
- +4 more secondary outcomes
Study Arms (2)
Lower thoracic epiduarl
EXPERIMENTALbefore induction of anesthesia,first the investigators identify the correct targeted thoracic level. All epidural block will be performed under all aseptic precautions with a 17-gauge Tuohy needle and 19 G flex-tip catheters. Using the loss of resistance to saline technique, catheter will be inserted 4 cm into the epidural space and a suitable test dose will be administered to exclude intravascular or sub-arachnoid injection. Bupivacaine 0.25% of 7.5-12 ml volume will be given bolus through the epidural catheter then continuous infusion of bupivacaine 0.1% will be infused at a rate of 5 ml/h up to 15ml/h .for breakthrough pain patient controlled analgesia (PCA) using nalbuphine 1 mg bolus , 10 min lockout period . The catheter will be removed under complete aseptic precautions after 48 hrs.
Erector spinae block
EXPERIMENTALbefore induction of anasthesia ,highfrequency linear ultrasound probe will be placed in a longitudinal parasagittal orientation 2.5-3 cm lateral to the T9 spinous process. A 21G 10 cm needle will be inserted using an in plane approach. The tip of the needle will be placed into the fascial plane on the deep aspect of the erector spinae muscle.confirmed by visible fluid spread lifting the erector spinae muscle off the bony shadow of the transverse process on ultrasonographic imaging.Then the catheter placement 5cm into the space under the erector spinae muscle and suitable test dose will be administered . Bupivacaine 0.25% of 7.5-12 ml volume will be given bolus through the catheter then continuous infusion of bupivacaine 0.1% will be infused at a rate of 5 ml/h up to 15 ml/h , for breakthrough pain patient controlled analgesia (PCA) using nalbuphine 1mg bolus,10 min lockout period.The catheter will be removed under complete aseptic precautions after 48 hrs.
Interventions
before induction of anesthesia,first the investigators identify the correct targeted thoracic level. All epidural block will be performed under all aseptic precautions with a 17-gauge Tuohy needle and 19 G flex-tip catheters. Using the loss of resistance to saline technique, catheter will be inserted 4 cm into the epidural space and a suitable test dose will be administered to exclude intravascular or sub-arachnoid injection. Bupivacaine 0.25% of 7.5-12 ml volume will be given bolus through the epidural catheter then continuous infusion of bupivacaine 0.1% will be infused at a rate of 5 ml/h up to 15ml/h .for breakthrough pain patient controlled analgesia (PCA) using nalbuphine 1 mg bolus , 10 min lockout period . The catheter will be removed under complete aseptic precautions after 48 hrs.
before induction of anasthesia ,highfrequency linear ultrasound probe will be placed in a longitudinal parasagittal orientation 2.5-3 cm lateral to the T9 spinous process. A 21G 10 cm needle will be inserted using an in plane approach. The tip of the needle will be placed into the fascial plane on the deep aspect of the erector spinae muscle.confirmed by visible fluid spread lifting the erector spinae muscle off the bony shadow of the transverse process on ultrasonographic imaging.Then the catheter placement 5cm into the space under the erector spinae muscle and suitable test dose will be administered . Bupivacaine 0.25% of 7.5-12 ml volume will be given bolus through the catheter then continuous infusion of bupivacaine 0.1% will be infused at a rate of 5 ml/h up to 15 ml/h , for breakthrough pain patient controlled analgesia (PCA) using nalbuphine 1mg bolus,10 min lockout period.The catheter will be removed under complete aseptic precautions after 48 hrs.
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years with a body mass index (BMI) of 18-35 kg/m2
- patients with the American Society of Anesthesiologists (ASA) physical status I/II,
- Patients scheduled for elective Percutaneous Nephrolithotomy.
You may not qualify if:
- Contraindication to local anesthesia :
- Allergy to local anaesthetics , Infection at the site of injection , Coagulopathy
- Chronic pain syndromes
- Prolonged opioid medication
- Patients who received any analgesic 24 h before surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
- Paravertebral block for surgical anesthesia of percutaneous nephrolithotomy
- abdominal wall blocks
- Thoracic paravertebral block for postoperative pain management in percutaneous nephrolithotomy patient
- Thoracic paravertebral block versus epidural anesthesia combined with moderate sedation for percutaneous nephrolithotomy
- Percutaneous nephrolithotomy under a multimodal analgesia regime.
- Application of TAP block in laparoscopic urologic surgery: Current status and future directions.
- Pulmonary complications following percutaneous nephrolithotomy
- Multimodal analgesia for controlling acute postoperative pain.
- The Erector Spinae Plane Block
- The Erector Spinae Plane Block Provides Visceral Abdominal Analgesia in Bariatric Surgery
- Use of the ultrasound-guided erector spinae plane block in breast surgery
- Erector Spinae Plane Blocks Provide Analgesia for Breast and Axillary Surgery
- Continuous Erector Spinae Plane block for thoracic surgery in a pediatric patient
- Erector Spinae Plane Block Versus Retrolaminar Block
- A Cadaveric Study Investigating the Mechanism of Action of Erector Spinae Blockade.
- Local anaesthetics and regional anaesthesia for preventing chronic pain after surgery
- Epidural catheter analgesia for the management of postoperative pain.
- Analgesia in thoracic surgery
- Paravertebral block with ropivacaine 0.5% versus systemic analgesia for pain relief after thoracotomy
- A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy
- Efficacy of ultrasound-guided erector spinae plane block for analgesia after laparoscopic cholecystectomy
Study Officials
- STUDY CHAIR
Mohamed Mohamed Abd EL Latif, Professor
Assuit University Hospital
- STUDY DIRECTOR
Amr Mohamed Ahmed Thabet, Lecturer
Assuit University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
January 25, 2023
First Posted
February 13, 2023
Study Start
January 11, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2025
Last Updated
January 11, 2024
Record last verified: 2024-01